Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells

  • Authors:
    • Motoi Mukai
    • Atsuko Kanzaki
    • Zhe-Sheng Chen
    • Hitoshi Miyashita
    • Tomoyuki Sumizawa
    • Tatsuhiko Furukawa
    • Misako Haraguchi
    • Yuji Takebayashi
    • Hideo Takamatsu
    • Shin-Ichi Akiyama
  • View Affiliations

  • Published online on: July 1, 2002     https://doi.org/10.3892/or.9.4.839
  • Pages: 839-844
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We previously reported that enhanced active efflux of cisplatin and increased GSH level were observed in KCP-4 cells. In the present study, KCP-4 cells were found to be cross-resistant to ultraviolet (UV) compared with parental KB-3-1 cells. Enhanced nucleotide excision repair (NER) was verified by time-dependent repair of UV-induced DNA damage. In addition, the amount of platinum bound to DNA after exposure to cisplatin decreased in a time-dependent manner in KCP-4 cells and this was reversed by aphidicolin, a DNA polymerase inhibitor. In stationary phase cultures, aphidicolin increased the sensitivity of KCP-4 cells to cisplatin. The expression of xeroderma pigmentosum complementation group F (XPF), an endonuclease involved in NER, was upregulated in KCP-4 cells. In KCP-4 cells the expression of hMSH6, one of the mismatch repair (MMR) factors, was decreased compared to parental KB-3-1 and revertant KCP-4R cells. However, KCP-4 cells were cross-resistant to oxaliplatin, and microsatellite instability was not observed in them. These findings suggest that the enhanced NER activity for DNA damage caused by cisplatin may be involved in cisplatin resistance in KCP-4 cells.

Related Articles

Journal Cover

July-August 2002
Volume 9 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Mukai M, Kanzaki A, Chen Z, Miyashita H, Sumizawa T, Furukawa T, Haraguchi M, Takebayashi Y, Takamatsu H, Akiyama S, Akiyama S, et al: Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells. Oncol Rep 9: 839-844, 2002
APA
Mukai, M., Kanzaki, A., Chen, Z., Miyashita, H., Sumizawa, T., Furukawa, T. ... Akiyama, S. (2002). Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells. Oncology Reports, 9, 839-844. https://doi.org/10.3892/or.9.4.839
MLA
Mukai, M., Kanzaki, A., Chen, Z., Miyashita, H., Sumizawa, T., Furukawa, T., Haraguchi, M., Takebayashi, Y., Takamatsu, H., Akiyama, S."Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells". Oncology Reports 9.4 (2002): 839-844.
Chicago
Mukai, M., Kanzaki, A., Chen, Z., Miyashita, H., Sumizawa, T., Furukawa, T., Haraguchi, M., Takebayashi, Y., Takamatsu, H., Akiyama, S."Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells". Oncology Reports 9, no. 4 (2002): 839-844. https://doi.org/10.3892/or.9.4.839